G1 Therapeutics Inc

NASDAQ GTHX

Data sourced from iex and EODHD
Download Data

G1 Therapeutics Inc Income Statement 2015 - 2024

This table shows the Income Statement for G1 Therapeutics Inc going from 2015 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31
Revenue
M 84 83 78 89 57 51 47 28 24 31 42 64 60 45 29 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1
Cost of Revenue
M 7 7 7 5 5 4 3 3 2 2 2 1 0 - -65 -42 -18 0 84 77 71 71 52 36 17 0 0 0 0 0 16 16 16 16
Gross Profit
M 77 75 71 84 53 48 44 26 22 29 41 63 59 45 93 44 18 0 -84 -77 -71 -71 -52 -36 -17 0 0 0 0 0 -12 -12 -12 -12
Operating Expenses
M 100 115 132 151 168 184 187 188 185 172 170 160 149 110 170 145 121 129 35 29 23 19 29 40 52 61 54 45 37 30 23 17 9 3
Selling, General, and Administrative Expenses (SG&A)
M 66 74 83 92 100 104 104 103 101 97 97 91 80 68 56 49 44 40 35 29 23 19 14 11 9 7 6 5 4 5 7 6 5 3
Research and Development (R&D) Expenses
M 36 44 53 64 72 83 87 88 86 76 73 70 69 73 81 86 91 89 84 77 71 71 67 65 60 54 48 40 32 25 29 23 17 13
Other Operating Expenses
M -1 -3 -4 -5 -5 -4 -4 -3 -2 -1 0 0 0 0 65 42 18 0 -84 -77 -71 -71 -52 -36 -17 0 0 0 0 0 -13 -13 -13 -13
Costs and Expenses
M 96 111 129 146 163 180 183 185 183 170 127 82 39 - 101 112 121 129 35 29 23 19 29 40 52 61 54 45 37 30 20 13 6 0
Operating Income
M -23 -40 -61 -67 -115 -136 -143 -162 -164 -142 -129 -98 -90 -96 -109 -133 -135 -129 -119 -105 -94 -89 -80 -76 -69 -61 -54 -45 -37 -30 -35 -29 -21 -15
Interest Expense
M 9 6 7 12 11 10 9 8 6 5 3 3 3 2 1 0 - - 2 2 2 4 2 2 2 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M -3 -3 -4 -6 -9 -10 -8 -5 -3 0 0 0 -1 0 1 3 5 7 7 7 6 4 2 2 1 1 1 0 0 0 -5 -5 -5 -5
EBT
M -27 -45 -68 -75 -124 -146 -152 -171 -170 -147 -133 -101 -93 -98 -108 -130 -130 -122 -111 -99 -89 -85 -78 -74 -68 -60 -54 -44 -37 -30 -40 -34 -26 -20
Income Tax Provision
M 3 8 8 8 9 7 6 5 3 1 1 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income after Tax
M -20 -53 -76 -83 -133 -152 -159 -176 -174 -148 -134 -103 -95 -68 -78 -67 -35 -59 -48 -68 -89 -85 -78 -74 -68 -60 -54 -45 -37 -30 -40 -34 -26 -20
Non-Controlling Interest
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -8 -8 -7 -3 9 9 9 4 1 1 1 1
Net Income
M 9 -19 -53 -78 -126 -148 -154 -171 -171 -148 -134 -103 -95 -99 -109 -130 -130 -122 -111 -99 -89 -85 -106 -102 -97 -93 -83 -67 -52 -35 -22 -22 -22 -22
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 54,207,189.00 54,076,251.50 52,023,071.25 49,778,474.00 45,195,273.00 42,955,089.75 42,684,641.75 42,580,699.50 42,433,736.25 41,937,142.75 40,814,464.75 39,720,872.50 38,637,462.00 37,877,185.75 37,760,338.00 37,643,132.00 37,564,311.50 37,498,626.00 37,402,879.75 36,475,144.00 35,302,892.75 33,293,765.25 31,333,074.50 29,955,379.25 25,311,927.75 24,637,768.75 22,404,998.50 20,432,681.75 21,988,000.25 20,429,389.00 20,429,389.00 20,429,389.00 20,429,389.00 -
EBITDA
M -21 -37 -58 -63 -113 -135 -143 -163 -164 -142 -129 -98 -90 -96 -109 -133 -135 -129 -118 -105 -94 -89 -80 -75 -69 -61 -54 -45 -37 -30 -20 -13 -6 -
Depreciation and Amortization
M 1 2 2 3 3 1 1 0 0 0 0 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
EBIT
M -22 -38 -60 -65 -115 -136 -143 -163 -164 -143 -129 -98 -91 -97 -109 -133 -135 -129 -119 -105 -95 -89 -80 -76 -69 -61 -54 -45 -37 -30 -35 -29 -21 -15
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Tax Rate (Effective)
% -0.41 -4.78 -2.88 -2.84 -7.68 -4.43 -4.22 -3.14 -1.71 -0.62 -0.94 -2.92 -2.82 -3.59 -2.81 0.12 0.40 0.33 0.26 0.17 0.13 0.06 0.00 0.00 0.00 -0.08 -0.23 -0.23 -0.23 -0.23 -0.08 -0.11 -0.16 0.00
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Gross Profit Margin
% 88.95 87.99 87.68 92.76 91.28 91.67 92.48 90.61 89.86 91.86 93.47 96.51 99.57 100.00 100.00 100.00 - - - - - - - - - - - - - - -2,338.70 -2,338.70 -2,338.70 -2,338.70
Operating Income Margin
% -57.11 -91.20 -151.53 -141.11 -235.30 -355.03 -441.81 -630.70 -687.88 -563.33 -437.61 -235.03 -450.52 -540.83 -738.46 -1,440.28 - - - - - - - - - - - - - - -2,954.79 -2,954.79 -2,954.79 -2,954.79
Net Income Margin
% 20.55 -96.30 -173.63 -157.02 -255.43 -380.32 -470.87 -662.62 -718.58 -586.89 -452.57 -245.00 -460.37 -551.83 -751.15 -1,458.41 - - - - - - - - - - - - - - -4,155.17 -4,155.17 -4,155.17 -4,155.17
EBITDA Ratio
% -55.90 -87.81 -146.27 -135.42 -230.26 -352.49 -441.92 -630.98 -688.17 -563.34 -437.09 -234.85 -450.07 -540.46 -737.82 -1,438.64 - - - - - - - - - - - - - - - - - -
EBIT Ratio
% -56.65 -90.75 -151.07 -140.40 -235.30 -355.03 -442.87 -632.11 -689.60 -565.09 -438.53 -235.83 -452.44 -543.34 -741.79 -1,446.03 - - - - - - - - - - - - - - -2,954.79 -2,954.79 -2,954.79 -2,954.79
EBT Ratio
% -63.67 -99.31 -163.44 -153.78 -252.96 -377.85 -468.51 -659.90 -715.04 -583.11 -449.12 -242.32 -458.53 -549.70 -749.40 -1,458.41 - - - - - - - - - - - - - - -3,881.80 -3,881.80 -3,881.80 -3,881.80

StockViz Staff

September 19, 2024

Any question? Send us an email